Back to results
US 2023/0111672 A1Published application
Compositions and methods for production of recombinant adeno-associated virus
AssigneeThe Regents of the University of California
InventorsDavid Vernon Schaffer, Hyuncheol Lee, Christopher Ryan Barnes
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for producing recombinant adeno-associated virus (rAAV) virions. The present disclosure provides compositions for producing rAAV virions.
Claims22
A method for producing recombinant adeno-associated virus (rAAV) virions, the method comprising:
- culturing a eukaryotic cell in a culture medium, wherein the eukaryotic cell comprises one or more nucleic acids comprising:
- a) nucleotide sequences encoding AAV rep and cap gene products;
- and
- b) a nucleotide sequence encoding one or more heterologous gene products,
- wherein the culture medium comprises a cell cycle blocking agent in a concentration of from about 1 mM to about 100 mM and
- wherein said culturing results in production of the rAAV virions.
3 more elements
A composition for the production of recombinant adeno-associated virus (rAAV) virions, the composition comprising:
- a) eukaryotic cell comprising one or more nucleic acids comprising:
- i) nucleotide sequences encoding AAV rep and cap gene products;
- and
- ii) a nucleotide sequence encoding one or more heterologous gene products;
- and
- b) a culture medium comprising a cell cycle blocking agent in a concentration of from about 1 mM to about 100 mM.
3 more elements
Dependencies are inferred from the claim text.